BackModerna Overview
Moderna Inc

Moderna Target Price

Analysts' average 12-month price target for Moderna is $46.

Get informed when a big investor buys or sells

+ Follow

Share Price

$62.96

Average Target Price

$46.4426.2% downside

9 analysts in the last 4 months

High: $77 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-21Goldman Sachs$676.4% upsideOpen
2026-07-20Wolfe ResearchAlexandria Hammond$2560.3% downsideOpen
2026-07-08Morgan Stanley$3938.1% downsideOpen
2026-07-07RBC Capital$4528.5% downsideOpen
2026-06-26Piper Sandler$7722.3% upsideOpen
2026-05-04UBS$4528.5% downsideOpen
2026-05-04RBC CapitalLuca Issi$3839.6% downsideOpen
2026-05-01Morgan Stanley$3347.6% downsideOpen
2026-05-01Goldman Sachs$4922.2% downsideOpen
2026-03-03JefferiesAndrew Tsai$3741.2% downsideOpen
2026-02-17RBC CapitalLuca Issi$3052.4% downsideOpen
2026-02-17Evercore ISICory Kasimov$3544.4% downsideOpen
2026-02-17Bernstein$4528.5% downsideOpen
2026-02-16UBS$3642.8% downsideOpen
2026-02-16Morgan Stanley$3052.4% downsideOpen
2026-01-06UBS$3446% downsideOpen
2025-12-12Jefferies$3052.4% downsideOpen
2025-12-12Morgan Stanley$2855.5% downsideOpen
2025-11-21Piper Sandler$630.1% upsideOpen
2025-11-21RBC CapitalLuca Issi$2560.3% downsideOpen
2025-11-21UBS$1871.4% downsideOpen
2025-11-20Wolfe Research$1773% downsideOpen
2025-11-17Berenberg Bank$2855.5% downsideOpen
2025-10-23UBS$4036.5% downsideOpen
2025-08-22Leerink Partners$1576.2% downsideOpen
2025-08-01J.P. MorganJessica Fye$2658.7% downsideOpen
2025-08-01CitigroupGeoff Meacham$4036.5% downsideOpen
2025-08-01Morgan StanleyMatthew Harrison$3249.2% downsideOpen
2025-08-01Evercore ISICory Kasimov$3249.2% downsideOpen
2025-02-14J.P. MorganJessica Fye$4528.5% downsideOpen
2025-02-14Evercore ISICory Kaimov$5020.6% downsideOpen
2024-11-18Piper SandlerEdward Tenthoff$699.6% upsideOpen
2024-11-18HSBCYifeng Liu$587.9% downsideOpen
2024-10-17BernsteinCourtney Breen$5512.6% downsideOpen
2024-10-14JefferiesMichael Yee$5512.6% downsideOpen
2024-09-13Piper SandlerEdward Tenthoff$11582.7% upsideOpen
2024-09-13RBC CapitalLuca Issi$7519.1% upsideOpen
2024-09-13Loop Capital MarketsLeah Rush Cann$238278% upsideOpen
2024-09-12JefferiesMichael Yee$653.2% upsideOpen
2024-09-12Evercore ISICory Kasimov$10566.8% upsideOpen
2024-09-12Morgan StanleyMatthew Harrison$9449.3% upsideOpen
2024-09-12JefferiesMichael Yee$12090.6% upsideOpen
2024-08-28HSBCYifeng Liu$8230.2% upsideOpen
2024-08-28Robert W. BairdPeter Arment$220249.4% upsideOpen
2024-08-06Deutsche BankEmmanuel Papadakis$8027.1% upsideOpen
2024-08-05RBC CapitalLuca Issi$9042.9% upsideOpen
2024-08-02Piper SandlerEdward Tenthoff$157149.4% upsideOpen
2024-06-12OppenheimerHartaj Singh$179184.3% upsideOpen
2024-06-10Loop Capital MarketsLeah Rush Cann$310392.4% upsideOpen
2024-06-07JefferiesMichael Yee$180185.9% upsideOpen

Moderna (MRNA) FAQ

The latest target price for MRNA is $46. Investors often review this figure alongside Moderna's historical trend and sector peers before judging valuation or financial health.

Moderna trades near $62.96 while the consensus target sits at $46 (26.2% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting MRNA's target price ($46), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Moderna's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.